ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
OTM recognised as the Leading Travel Trade Show in India and Asia, for the Second Year in a Row, in a custom study commissioned by Fairfest Media and conducted by NielsenIQ
The customised study, commissioned by Fairfest Media and conducted by NielsenIQ, the…
Chandigarh University Fulfills Dreams of 388 students for Study in USA, 59 students in Australia, 48 students in Canada & 13 students in UK
CU Empowers Students with Global Exposure from Harvard to Walt Disney World…
Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience
New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and…
